Anti-PD-1 Immunotherapy and Bee Venom for Relapsed and Refractory Liposarcoma: A Case Report

Cancer immunotherapies, including immune checkpoint inhibitors, elicit long-term clinical responses but many cancer patients do not respond. Intensive efforts are therefore underway to identify additional immune pathways that may be modulated to enhance the efficacy of existing immunotherapies. Bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wei, Zhang, Yeke, Yang, Gaoyi, Geng, Yanhua, Chen, Da, Wang, Jun, Ye, Yang, Wang, Huaichong, Xia, Dajing, Hu, Fuliang, Jiang, Jing, Xu, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117145/
https://www.ncbi.nlm.nih.gov/pubmed/33996596
http://dx.doi.org/10.3389/fonc.2021.668992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117145/
https://www.ncbi.nlm.nih.gov/pubmed/33996596
http://dx.doi.org/10.3389/fonc.2021.668992

Ejemplares similares